A Swiss study published in the journal, Forensic Sciences Research, has found that CBD-dominant cannabis, which is legal in Switzerland, does not impact driving ability.
A recent study out of Australia found that the THC levels recorded in blood and saliva tests are inconsistent indicators of impairment.
Published in the journal, Neuroscience & Biobehavioral Reviews, that study concluded the use of per se limits as a means of identifying cannabis-impaired drivers should be reconsidered. “It seems there is a significant risk of unimpaired individuals being mistakenly identified as ‘cannabis-impaired’ (and vice-versa) under this approach,” researchers wrote.
In the Swiss study, all 33 participants exceeded the Driving Under the Influence of Drugs (DUID) legal limit for THC in blood after smoking CBD-rich marijuana, despite showing no symptoms of impairment.
Researchers also found that there were no significant differences between those who consumed the CBD flower
Read full article on The Growth Op
